Diabetes and the Retina: The Role of Medical Treatment. [PDF]
J DiabetesBloomgarden Z.
europepmc +1 more source
Fenofibrate alleviates sepsis-associated acute kidney injury by enhancing renal fatty acid oxidation. [PDF]
BMC Pharmacol ToxicolZeng S +7 more
europepmc +1 more source
PsychoPharm aggregated risk score (PARS): a multidimensional tool to flag high-risk pharmacotherapy in psychiatric patients. [PDF]
Front PharmacolGoldiş FD +4 more
europepmc +1 more source
Systemic strategies to prevent early diabetic retinopathy: targeting polyunsaturated fatty acid metabolism and eicosanoid signaling. [PDF]
Front Med (Lausanne)Aqil MS +5 more
europepmc +1 more source
Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model. [PDF]
Naunyn Schmiedebergs Arch PharmacolTawfik MF +7 more
europepmc +1 more source
Rapid Glycemic Correction and the Paradox of Retinopathy Progression. [PDF]
Endocrinol Metab (Seoul)Choe HJ, Hong EG.
europepmc +1 more source
Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend. [PDF]
Int J Mol MedLin PY +14 more
europepmc +1 more source
Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes. [PDF]
Int J Mol SciKovalenko AA +5 more
europepmc +1 more source
Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease. [PDF]
Front PharmacolLi X, Zhang J, Wei B, Tong H.
europepmc +1 more source
Oral therapies for diabetic retinopathy: Addressing an unmet need or a distant prospect? [PDF]
J Int Med ResEmpeslidis T +3 more
europepmc +1 more source